Table 3.
Effects of casein glycomacropeptide on growth performance and fecal scores of weanling piglets.
| Item | Control group | K88 challenged group | CGMP treated group | P-value |
|---|---|---|---|---|
| Body weight, kg | ||||
| Day 1 | 8.09 ± 0.39 | 7.59 ± 0.37 | 7.69 ± 0.42 | 0.629 |
| Day 7 | 9.37 ± 0.42 | 9.13 ± 0.52 | 9.55 ± 0.64 | 0.854 |
| Day 12 | 10.94 ± 0.74 | 8.79 ± 0.75 | 10.43 ± 0.52 | 0.098 |
| ADFI, g/d | ||||
| Days 1–7 | 307.14 ± 47.56 | 342.86 ± 53.61 | 344.05 ± 18.48 | 0.793 |
| Days 8–12 | 470.90 ± 60.60 | 248.27 ± 63.91 | 285.52 ± 106.90 | 0.189 |
| Days 1–12 | 375.38 ± 52.95 | 303.44 ± 53.59 | 314.88 ± 29.75 | 0.519 |
| ADG, g/d | ||||
| Days 1–7 | 216.43 ± 41.26 | 220.48 ± 28.97 | 266.57 ± 34.29 | 0.574 |
| Days 8–12 | 267.67 ± 72.30A | −68.50 ± 50.08B | 175.80 ± 85.96A | 0.009 |
| Days 1–12 | 237.78 ± 53.60 | 100.07 ± 36.92 | 228.75 ± 26.78 | 0.061 |
| F/G1 | ||||
| Days 1–7 | 1.45 ± 0.09 | 1.57 ± 0.18 | 1.26 ± 0.14 | 0.339 |
| Days 1–12 | 1.64 ± 0.14 | 3.78 ± 1.11 | 1.46 ± 0.07 | 0.078 |
| Fecal scores | ||||
| Days 1–7 | 0.29 ± 0.09 | 0.14 ± 0.43 | 0.21 ± 0.09 | 0.483 |
| Days 8–12 | 0.20 ± 0.06A | 0.70 ± 0.17B | 0.20 ± 0.03A | 0.048 |
| Days 1–12 | 0.25 ± 0.06 | 0.38 ± 0.11 | 0.21 ± 0.05 | 0.630 |
Results are given as mean ± SEM.
CGMP = casein glycomacropeptide; ADFI = average daily feed intake; ADG = average daily gain; F/G = feed/gain.
A,BDifferent superscript letters within a row represent statistically significant differences among groups (P < 0.05).
1
The data F/G on days 8–12 were unable to calculate due to the minus ADG on days 8–12.